These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Studies on the neuroendocrine role of serotonin. Jørgensen HS Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678 [TBL] [Abstract][Full Text] [Related]
24. Serotonergic mechanisms in aggression. Olivier B Novartis Found Symp; 2005; 268():171-83; discussion 183-9, 242-53. PubMed ID: 16206880 [TBL] [Abstract][Full Text] [Related]
25. [Blockade of 5-HT2 receptors as a mechanism of antihypertensive action of ketanserin]. Prostran M Srp Arh Celok Lek; 1994; 122(3-4):99-102. PubMed ID: 17972821 [TBL] [Abstract][Full Text] [Related]
26. [Implication of serotonin in the control of vigilance states as revealed by knockout-mouse studies]. Adrien J J Soc Biol; 2004; 198(1):30-6. PubMed ID: 15146953 [TBL] [Abstract][Full Text] [Related]
27. Research update on serotonin function in bulimia nervosa and anorexia nervosa. Wolfe BE; Metzger E; Jimerson DC Psychopharmacol Bull; 1997; 33(3):345-54. PubMed ID: 9550877 [TBL] [Abstract][Full Text] [Related]
28. Pharmacologic profile of amphetamine derivatives at various brain recognition sites: selective effects on serotonergic systems. Battaglia G; De Souza EB NIDA Res Monogr; 1989; 94():240-58. PubMed ID: 2514364 [TBL] [Abstract][Full Text] [Related]
29. Multiple serotonin receptors and their physiological significance. Peroutka SJ; Snyder SH Fed Proc; 1983 Feb; 42(2):213-7. PubMed ID: 6337063 [TBL] [Abstract][Full Text] [Related]
30. [Hypertension and vascular diseases: molecular and cellular mechanisms]. Lüscher TF Schweiz Med Wochenschr; 1995 Feb; 125(7):270-82. PubMed ID: 7878405 [TBL] [Abstract][Full Text] [Related]
31. Effect of long-term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. A double-blind, placebo-controlled cross-over study. Arneklo-Nobin B; Elmér O; Akesson A Int Angiol; 1988; 7(1):19-25. PubMed ID: 3290356 [TBL] [Abstract][Full Text] [Related]
33. Neuroendocrine mechanisms during reversible hypovolaemic shock in humans with emphasis on the histaminergic and serotonergic system. Matzen SH Acta Physiol Scand Suppl; 1995; 628():1-31. PubMed ID: 8801774 [TBL] [Abstract][Full Text] [Related]
34. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility. Gershon MD Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849 [TBL] [Abstract][Full Text] [Related]
37. [The world of serotonin and its receptors. Physiopathologic, clinical, and therapeutic aspects]. Marco Igual M Med Clin (Barc); 1993 Jun; 101(4):144-53. PubMed ID: 8355545 [No Abstract] [Full Text] [Related]
38. Is there a relationship between serotonin receptor subtypes and selectivity of response in specific psychiatric illnesses? Montgomery SA; Fineberg N Br J Psychiatry Suppl; 1989 Dec; (8):63-9. PubMed ID: 2692641 [TBL] [Abstract][Full Text] [Related]
39. Serotonin and brain development. Sodhi MS; Sanders-Bush E Int Rev Neurobiol; 2004; 59():111-74. PubMed ID: 15006487 [TBL] [Abstract][Full Text] [Related]